Latest Revenue Recognition News

Orcoda has secured a lucrative multi-year contract with Wagner Corporation to deliver workforce logistics and facilities management at Wellcamp Business Park, leveraging its AI-driven Contractor360 platform.

Vection Technologies has locked in approximately $2.3 million in new AI-related contracts spanning healthcare, luxury fashion, public services, airport passenger assistance, and security, pushing total orders since April 2026 to around $7 million.

HighCom Limited has updated its FY26 second half guidance, now forecasting EBITDA losses between $1.2 million and $1.6 million, an improvement on the first half but shy of earlier breakeven expectations, alongside revenue growth of 70% to 100%.

Electro Optic Systems (ASX:EOS) reports sustained demand driven by global conflicts, launches MARSS business in Europe, and updates 2026 revenue outlook with base business guidance of $240m to $270m.

Marlin Global’s portfolio lagged the broader market in May 2026, weighed down by semiconductor underexposure and near-term revenue challenges in key holdings, while AI-focused stocks powered a narrow rally.

Austco Healthcare expects FY26 revenue between A$90 million and A$95 million, driven by strong sales and a significant US rollout. Net profit after tax is forecast to jump over 50%, supported by operational growth and a one-off benefit.

Trajan Group Holdings reports steady market demand and successful cost initiatives in H2 FY26 but warns of a $4 million revenue hit from Australian dollar appreciation.

UOA Development Bhd’s Q1 2026 results reveal a decline in revenue and profit compared to last year, despite a solid RM130.7 million in new property sales and a substantial unbilled sales pipeline.

Papyrus Australia has fulfilled a critical contract milestone by delivering 200 biodegradable Collar Keeper product samples to TBS Mining Solutions, enabling the next phase of product testing despite a slight delay.

SKS Technologies has landed a $22 million contract to deliver integrated electrical systems for a major retailer's new Melbourne headquarters, pushing its order book to $355 million amid a booming project pipeline.

Resonance Health upgrades its FY26 underlying EBITDA guidance to $2.6 million, driven by operational efficiencies and growth in its Software-as-Medical Devices segment, despite a slight revenue timing delay.

The Hydration Pharmaceuticals Company Limited (ASX: HPC) temporarily halted trading to relodge its FY25 Annual Report, revealing a $2.86 million loss driven by US market rationalisation and ongoing cost-cutting.